182 related articles for article (PubMed ID: 11840447)
1. Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens.
Scaletti C; Vultaggio A; Bonifacio S; Emmi L; Torricelli F; Maggi E; Romagnani S; Piccinni MP
Arthritis Rheum; 2002 Feb; 46(2):445-50. PubMed ID: 11840447
[TBL] [Abstract][Full Text] [Related]
2. [Microchimera. New thought process for pathogenesis of systemic scleroderma].
Haustein UF
Hautarzt; 2000 Feb; 51(2):59-62. PubMed ID: 10743573
[TBL] [Abstract][Full Text] [Related]
3. Microchimerism and systemic sclerosis.
Scaletti C; Vultaggio A; Maggi E; Romagnani S; Piccinni MP
Int Arch Allergy Immunol; 2001 Jul; 125(3):196-202. PubMed ID: 11490151
[TBL] [Abstract][Full Text] [Related]
4. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis.
Artlett CM; Smith JB; Jimenez SA
N Engl J Med; 1998 Apr; 338(17):1186-91. PubMed ID: 9554859
[TBL] [Abstract][Full Text] [Related]
5. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
[TBL] [Abstract][Full Text] [Related]
6. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma.
Nelson JL; Furst DE; Maloney S; Gooley T; Evans PC; Smith A; Bean MA; Ober C; Bianchi DW
Lancet; 1998 Feb; 351(9102):559-62. PubMed ID: 9492775
[TBL] [Abstract][Full Text] [Related]
7. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis.
Mavalia C; Scaletti C; Romagnani P; Carossino AM; Pignone A; Emmi L; Pupilli C; Pizzolo G; Maggi E; Romagnani S
Am J Pathol; 1997 Dec; 151(6):1751-8. PubMed ID: 9403725
[TBL] [Abstract][Full Text] [Related]
8. Soluble HLA-G Expression Inversely Correlates With Fetal Microchimerism Levels in Peripheral Blood From Women With Scleroderma.
Di Cristofaro J; Karlmark KR; Kanaan SB; Azzouz DF; El Haddad M; Hubert L; Farge-Bancel D; Granel B; Harlé JR; Hachulla E; Pardoux E; Roudier J; Picard C; Lambert NC
Front Immunol; 2018; 9():1685. PubMed ID: 30158921
[TBL] [Abstract][Full Text] [Related]
9. Analysis of soluble and cell surface factors regulating anti-DNA topoisomerase I autoantibody production demonstrates synergy between Th1 and Th2 autoreactive T cells.
Kuwana M; Medsger TA; Wright TM
J Immunol; 2000 Jun; 164(12):6138-46. PubMed ID: 10843663
[TBL] [Abstract][Full Text] [Related]
10. Quantification of fetal microchimeric cells in clinically affected and unaffected skin of patients with systemic sclerosis.
Sawaya HH; Jimenez SA; Artlett CM
Rheumatology (Oxford); 2004 Aug; 43(8):965-8. PubMed ID: 15199216
[TBL] [Abstract][Full Text] [Related]
11. Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis.
Johnson KL; Nelson JL; Furst DE; McSweeney PA; Roberts DJ; Zhen DK; Bianchi DW
Arthritis Rheum; 2001 Aug; 44(8):1848-54. PubMed ID: 11508438
[TBL] [Abstract][Full Text] [Related]
12. Microchimerism of maternal origin persists into adult life.
Maloney S; Smith A; Furst DE; Myerson D; Rupert K; Evans PC; Nelson JL
J Clin Invest; 1999 Jul; 104(1):41-7. PubMed ID: 10393697
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of class II major histocompatibility complex and intercellular adhesion molecule 1 expression on scleroderma fibroblasts and endothelial cells by interferon-gamma and tumor necrosis factor alpha in the early disease stage.
Gruschwitz MS; Vieth G
Arthritis Rheum; 1997 Mar; 40(3):540-50. PubMed ID: 9082943
[TBL] [Abstract][Full Text] [Related]
14. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma.
Evans PC; Lambert N; Maloney S; Furst DE; Moore JM; Nelson JL
Blood; 1999 Mar; 93(6):2033-7. PubMed ID: 10068676
[TBL] [Abstract][Full Text] [Related]
15. Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis.
Artlett CM; Welsh KI; Black CM; Jimenez SA
Immunogenetics; 1997; 47(1):17-22. PubMed ID: 9382916
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus aggravates the autoimmune phenomenon in systemic autoimmune diseases.
Janahi EMA; Das S; Bhattacharya SN; Haque S; Akhter N; Jawed A; Wahid M; Mandal RK; Lohani M; Areeshi MY; Ramachandran VG; Almalki S; Dar SA
Microb Pathog; 2018 Jul; 120():132-139. PubMed ID: 29704668
[TBL] [Abstract][Full Text] [Related]
17. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
McMenamin C; Holt PG
J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
[TBL] [Abstract][Full Text] [Related]
18. Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis.
Parel Y; Aurrand-Lions M; Scheja A; Dayer JM; Roosnek E; Chizzolini C
Arthritis Rheum; 2007 Oct; 56(10):3459-67. PubMed ID: 17907151
[TBL] [Abstract][Full Text] [Related]
19. HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals.
Artlett CM; O'Hanlon TP; Lopez AM; Song YW; Miller FW; Rider LG
Arthritis Rheum; 2003 Sep; 48(9):2567-72. PubMed ID: 13130476
[TBL] [Abstract][Full Text] [Related]
20. Possible contribution of microchimerism to the pathogenesis of Sjögren's syndrome.
Endo Y; Negishi I; Ishikawa O
Rheumatology (Oxford); 2002 May; 41(5):490-5. PubMed ID: 12011370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
